The Immunobiology of IL-27

Advances in Immunology

Volumn 115, Issue , 2012, Pages 1-44

  Hall, Aisling O'Hara ^a   Silver, Jonathan S ^a   Hunter, Christopher A ^a  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF VETERINARY MEDICINE   (United States)

Author keywords

Adaptive Immunity; Cytokine; Immune regulation; Immunobiology; Innate Immunity; Receptors; Signaling; Subunits; T cells

Indexed keywords

ADENOVIRUS VECTOR; CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 27; INTERLEUKIN 27 RECEPTOR ALPHA; INTERLEUKIN RECEPTOR; NANOPARTICLE; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; ASTHMA; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROHN DISEASE; CYTOKINE PRODUCTION; DRUG TARGETING; ENTERITIS; GENETIC ENGINEERING; GENETIC SUSCEPTIBILITY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOBIOLOGY; INFECTION RESISTANCE; INFLAMMATION; INFLUENZA; INNATE IMMUNITY; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; LEISHMANIASIS; LISTERIA MONOCYTOGENES; LISTERIOSIS; LUPUS VULGARIS; MOLECULAR MECHANICS; MULTIPLE SCLEROSIS; MYCOBACTERIUM BOVIS; NEUROBLASTOMA; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS; TRICHURIASIS; TRICHURIS; TRICHURIS MURIS; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; TUBERCULOSIS; ULCERATIVE COLITIS; VIRAL GENE DELIVERY SYSTEM;

EID: 84861170066     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394299-9.00001-1     Document Type: Chapter

References (194)

1. Anderson C.F., Stumhofer J.S., Hunter C.A., Sacks D. IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection. J. Immunol. 2009, 183:4619-4627.
2. Andersson L.C., Gahmberg C.G., Kimura A.K., Wigzell H. Activated human T lymphocytes display new surface glycoproteins. Proc. Natl. Acad. Sci. USA 1978, 75:3455-3458.
3. Apetoh L., Quintana F.J., Pot C., Joller N., Xiao S., Kumar D., Burns E.J., Sherr D.H., Weiner H.L., Kuchroo V.K. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 2010, 11:854-861.
4. Artis D., Johnson L.M., Joyce K., Saris C., Villarino A., Hunter C.A., Scott P. Cutting edge: Early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection. J. Immunol. 2004, 172:4672-4675.
5. Artis D., Villarino A., Silverman M., He W., Thornton E.M., Mu S., Summer S., Covey T.M., Huang E., Yoshida H., et al. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J. Immunol. 2004, 173:5626-5634.
6. Awasthi A., Carrier Y., Peron J.P., Bettelli E., Kamanaka M., Flavell R.A., Kuchroo V.K., Oukka M., Weiner H.L. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 2007, 8:1380-1389.
7. Bardel E., Larousserie F., Charlot-Rabiega P., Coulomb-L'Hermine A., Devergne O. Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35. J. Immunol. 2008, 181:6898-6905.
8. Batten M., Ghilardi N. The biology and therapeutic potential of interleukin 27. J. Mol. Med. (Berl.) 2007, 85:661-672.
9. Batten M., Kljavin N.M., Li J., Walter M.J., de Sauvage F.J., Ghilardi N. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J. Immunol. 2008, 180:2752-2756.
10. Batten M., Li J., Yi S., Kljavin N.M., Danilenko D.M., Lucas S., Lee J., de Sauvage F.J., Ghilardi N. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 2006, 7:929-936.
11. Batten M., Ramamoorthi N., Kljavin N.M., Ma C.S., Cox J.H., Dengler H.S., Danilenko D.M., Caplazi P., Wong M., Fulcher D.A., et al. IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells. J. Exp. Med. 2010, 207:2895-2906.
12. Bazan J.F. Haemopoietic receptors and helical cytokines. Immunol. Today 1990, 11:350-354.
13. Bazan J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 1990, 87:6934-6938.
14. Betz U.A., Muller W. Regulated expression of gp130 and IL-6 receptor alpha chain in T cell maturation and activation. Int. Immunol. 1998, 10:1175-1184.
15. Biggioggero M., Gabbriellini L., Meroni P.L. Type I interferon therapy and its role in autoimmunity. Autoimmunity 2010, 43:248-254.
16. Boumendjel A., Tawk L., Malefijt Rde W., Boulay V., Yssel H., Pene J. IL-27 induces the production of IgG1 by human B cells. Eur. Cytokine Netw. 2006, 17:281-289.
17. Brod S.A., Scott M., Burns D.K., Phillips J.T. Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons. J. Interferon Cytokine Res. 1995, 15:115-122.
18. Cao Y., Doodes P.D., Glant T.T., Finnegan A. IL-27 induces a Th1 immune response and susceptibility to experimental arthritis. J. Immunol. 2008, 180:922-930.
19. Chae S.C., Li C.S., Kim K.M., Yang J.Y., Zhang Q., Lee Y.C., Yang Y.S., Chung H.T. Identification of polymorphisms in human interleukin-27 and their association with asthma in a Korean population. J. Hum. Genet. 2007, 52:355-361.
20. Charlot-Rabiega P., Bardel E., Dietrich C., Kastelein R., Devergne O. Signaling events involved in interleukin 27 (IL-27)-induced proliferation of human naive CD4+ T cells and B cells. J. Biol. Chem. 2011, 286:27350-27362.
21. Chen Q., Ghilardi N., Wang H., Baker T., Xie M.H., Gurney A., Grewal I.S., de Sauvage F.J. Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 2000, 407:916-920.
22. Chiyo M., Shimozato O., Iizasa T., Fujisawa T., Tagawa M. Antitumor effects produced by transduction of dendritic cells-derived heterodimeric cytokine genes in murine colon carcinoma cells. Anticancer Res. 2004, 24:3763-3767.
23. Chiyo M., Shimozato O., Yu L., Kawamura K., Iizasa T., Fujisawa T., Tagawa M. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Int. J. Cancer 2005, 115:437-442.
24. Cocco C., Morandi F., Airoldi I. Interleukin-27 and interleukin-23 modulate human plasmacell functions. J. Leukoc. Biol. 2011, 89:729-734.
25. Cohen J. IL-12 deaths: Explanation and a puzzle. Science 1995, 270:908.
26. Collison L.W., Chaturvedi V., Henderson A.L., Giacomin P.R., Guy C., Bankoti J., Finkelstein D., Forbes K., Workman C.J., Brown S.A., et al. IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 2010, 11:1093-1101.
27. Collison L.W., Pillai M.R., Chaturvedi V., Vignali D.A. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J. Immunol. 2009, 182:6121-6128.
28. Collison L.W., Workman C.J., Kuo T.T., Boyd K., Wang Y., Vignali K.M., Cross R., Sehy D., Blumberg R.S., Vignali D.A. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450:566-569.
29. Couper K.N., Blount D.G., Riley E.M. IL-10: The master regulator of immunity to infection. J. Immunol. 2008, 180:5771-5777.
30. Cox J.H., Kljavin N.M., Ramamoorthi N., Diehl L., Batten M., Ghilardi N. IL-27 promotes T cell-dependent colitis through multiple mechanisms. J. Exp. Med. 2011, 208:115-123.
31. Crabe S., Guay-Giroux A., Tormo A.J., Duluc D., Lissilaa R., Guilhot F., Mavoungou-Bigouagou U., Lefouili F., Cognet I., Ferlin W., et al. The IL-27 p28 subunit binds cytokine-like factor 1 to form a cytokine regulating NK and T cell activities requiring IL-6R for signaling. J. Immunol. 2009, 183:7692-7702.
32. Desgeorges A., Gabay C., Silacci P., Novick D., Roux-Lombard P., Grau G., Dayer J.M., Vischer T., Guerne P.A. Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid. J. Rheumatol. 1997, 24:1510-1516.
33. Devergne O., Birkenbach M., Kieff E. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc. Natl. Acad. Sci. USA 1997, 94:12041-12046.
34. Devergne O., Hummel M., Koeppen H., Le Beau M.M., Nathanson E.C., Kieff E., Birkenbach M. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 1996, 70:1143-1153.
35. Dibra D., Cutrera J., Xia X., Li S. WSX1 expression in tumors induces immune tolerance via suppression of effector immune cells. PLoS One 2011, 6:e19072.
36. Dibra D., Cutrera J.J., Xia X., Birkenbach M.P., Li S. Expression of WSX1 in tumors sensitizes IL-27 signaling-independent natural killer cell surveillance. Cancer Res. 2009, 69:5505-5513.
37. Diegelmann J., Olszak T., Goke B., Blumberg R.S., Brand S. A novel role for IL-27 as mediator of intestinal epithelial barrier protection mediated via differential STAT signaling and induction of antibacterial and anti-inflammatory proteins. J. Biol. Chem. 2011, 287:286-298.
38. Diveu C., McGeachy M.J., Boniface K., Stumhofer J.S., Sathe M., Joyce-Shaikh B., Chen Y., Tato C.M., McClanahan T.K., de Waal Malefyt R., et al. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J. Immunol. 2009, 182:5748-5756.
39. Dokmeci E., Xu L., Robinson E., Golubets K., Bottomly K., Herrick C.A. EBI3 deficiency leads to diminished T helper type 1 and increased T helper type 2 mediated airway inflammation. Immunology 2011, 132:559-566.
40. El-behi M., Ciric B., Yu S., Zhang G.X., Fitzgerald D.C., Rostami A. Differential effect of IL-27 on developing versus committed Th17 cells. J. Immunol. 2009, 183:4957-4967.
41. Elson C.O., Cong Y., Weaver C.T., Schoeb T.R., McClanahan T.K., Fick R.B., Kastelein R.A. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 2007, 132:2359-2370.
42. Fairhurst A., Wandstrat A., Wakeland E. Systemic lupus erythematosus: Multiple immunological phenotypes in a complex genetic disease. Adv. Immunol. 2006, 92:1-69.
43. Findlay E.G., Greig R., Stumhofer J.S., Hafalla J.C., de Souza J.B., Saris C.J., Hunter C.A., Riley E.M., Couper K.N. Essential role for IL-27 receptor signaling in prevention of Th1-mediated immunopathology during malaria infection. J. Immunol. 2010, 185:2482-2492.
44. Fitzgerald D.C., Zhang G.X., El-Behi M., Fonseca-Kelly Z., Li H., Yu S., Saris C.J., Gran B., Ciric B., Rostami A. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 2007, 8:1372-1379.
45. Fitzgerald K.A., Rowe D.C., Barnes B.J., Caffrey D.R., Visintin A., Latz E., Monks B., Pitha P.M., Golenbock D.T. LPS-TLR4 signaling to IRF-3/7 and NF-B involves the toll adapters TRAM and TRIF. J. Exp. Med. 2003, 198:1043-1055.
46. Frank A.C., Zhang X., Katsounas A., Bharucha J.P., Kottilil S., Imamichi T. Interleukin-27, an anti-HIV-1 cytokine, inhibits replication of hepatitis C virus. J. Interferon Cytokine Res. 2010, 30:427-431.
47. Franke A., Balschun T., Karlsen T.H., Hedderich J., May S., Lu T., Schuldt D., Nikolaus S., Rosenstiel P., Krawczak M., Schreiber S. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat. Genet. 2008, 40:713-715.
48. Fujimoto H., Hirase T., Miyazaki Y., Hara H., Ide-Iwata N., Nishimoto-Hazuku A., Saris C.J., Yoshida H., Node K. IL-27 inhibits hyperglycemia and pancreatic islet inflammation induced by streptozotocin in mice. Am. J. Pathol. 2011, 179:2327-2336.
49. Fujita H., Teng A., Nozawa R., Takamoto-Matsui Y., Katagiri-Matsumura H., Ikezawa Z., Ishii Y. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model. J. Immunol. 2009, 183:254-260.
50. Gazzinelli R.T., Wysocka M., Hieny S., Scharton-Kersten T., Cheever A., Kuhn R., Muller W., Trinchieri G., Sher A. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 1996, 157:798-805.
51. Greenwell-Wild T., Vazquez N., Jin W., Rangel Z., Munson P.J., Wahl S.M. Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon. Blood 2009, 114:1864-1874.
52. Guo B., Chang E.Y., Cheng G. The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J. Clin. Invest. 2008, 118:1680-1690.
53. Hamano S., Himeno K., Miyazaki Y., Ishii K., Yamanaka A., Takeda A., Zhang M., Hisaeda H., Mak T.W., Yoshimura A., Yoshida H. WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 2003, 19:657-667.
54. Hashimoto S.I., Suzuki T., Nagai S., Yamashita T., Toyoda N., Matsushima K. Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood 2000, 96:2206-2214.
55. Hashimoto Y., Kurita M., Matsuoka M. Identification of soluble WSX-1 not as a dominant-negative but as an alternative functional subunit of a receptor for an anti-Alzheimer's disease rescue factor Humanin. Biochem. Biophys. Res. Commun. 2009, 389:95-99.
56. Hibbert L., Pflanz S., De Waal Malefyt R., Kastelein R.A. IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J. Interferon Cytokine Res. 2003, 23:513-522.
57. Hisada M., Kamiya S., Fujita K., Belladonna M.L., Aoki T., Koyanagi Y., Mizuguchi J., Yoshimoto T. Potent antitumor activity of interleukin-27. Cancer Res. 2004, 64:1152-1156.
58. Hollegaard M.V., Bidwell J.L. Cytokine gene polymorphism in human disease: On-line databases, Supplement 3. Genes Immun. 2006, 7:269-276.
59. Holscher C., Atkinson R.A., Arendse B., Brown N., Myburgh E., Alber G., Brombacher F. A protective and agonistic function of IL-12p40 in mycobacterial infection. J. Immunol. 2001, 167:6957-6966.
60. Holscher C., Holscher A., Ruckerl D., Yoshimoto T., Yoshida H., Mak T., Saris C., Ehlers S. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J. Immunol. 2005, 174:3534-3544.
61. Hu S., Wong C.K., Lam C.W. Activation of eosinophils by IL-12 family cytokine IL-27: Implications of the pleiotropic roles of IL-27 in allergic responses. Immunobiology 2010, 216:54-65.
62. Huang N., Liu L., Wang X.Z., Liu D., Yin S.Y., Yang X.D. Association of interleukin (IL)-12 and IL-27 gene polymorphisms with chronic obstructive pulmonary disease in a Chinese population. DNA Cell Biol. 2008, 27:527-531.
63. Huber M., Steinwald V., Guralnik A., Brustle A., Kleemann P., Rosenplanter C., Decker T., Lohoff M. IL-27 inhibits the development of regulatory T cells via STAT3. Int. Immunol. 2008, 20:223-234.
64. Huising M.O. Phylogeny and evolution of class-I helical cytokines. J. Endocrinol. 2006, 189:1-25.
65. Hunter C.A., Ellis-Neyes L.A., Slifer T., Kanaly S., Grunig G., Fort M., Rennick D., Araujo F.G. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 1997, 158:3311-3316.
66. Igawa T., Nakashima H., Sadanaga A., Masutani K., Miyake K., Shimizu S., Takeda A., Hamano S., Yoshida H. Deficiency in EBV-induced gene 3 (EBI3) in MRL/lpr mice results in pathological alteration of autoimmune glomerulonephritis and sialadenitis. Mod. Rheumatol. 2009, 19:33-41.
67. Imamichi T., Yang J., Huang D.W., Brann T.W., Fullmer B.A., Adelsberger J.W., Lempicki R.A., Baseler M.W., Lane H.C. IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages. AIDS 2008, 22:39-45.
68. Imielinski M., Baldassano R.N., Griffiths A., Russell R.K., Annese V., Dubinsky M., Kugathasan S., Bradfield J.P., Walters T.D., Sleiman P., et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat. Genet. 2009, 41:1335-1340.
69. Iyer S.S., Ghaffari A.A., Cheng G. Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages. J. Immunol. 2010, 185:6599-6607.
70. Jankovic D., Kullberg M.C., Feng C.G., Goldszmid R.S., Collazo C.M., Wilson M., Wynn T.A., Kamanaka M., Flavell R.A., Sher A. Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 2007, 204:273-283.
71. Kalliolias G.D., Gordon R.A., Ivashkiv L.B. Suppression of TNF-{alpha} and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27. J. Immunol. 2010, 185:7047-7056.
72. Kalliolias G.D., Ivashkiv L.B. IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38. J. Immunol. 2008, 180:6325-6333.
73. Kalliolias G.D., Zhao B., Triantafyllopoulou A., Park-Min K.H., Ivashkiv L.B. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling. Arthritis Rheum. 2010, 62:402-413.
74. Kamiya S., Owaki T., Morishima N., Fukai F., Mizuguchi J., Yoshimoto T. An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells. J. Immunol. 2004, 173:3871-3877.
75. Karakhanova S., Bedke T., Enk A.H., Mahnke K. IL-27 renders DC immunosuppressive by induction of B7-H1. J. Leukoc. Biol. 2011, 89:837-845.
76. Karp C. Interferon β in multiple sclerosis: Is IL-12 suppression the key?. Immunol. Today 2000, 21:24-28.
77. Kastelein R.A., Hunter C.A., Cua D.J. Discovery and biology of IL-23 and IL-27: Related but functionally distinct regulators of inflammation. Annu. Rev. Immunol. 2007, 25:221-242.
78. Kido M., Takeuchi S., Sugiyama N., Esaki H., Nakashima H., Yoshida H., Furue M. T cell-specific overexpression of interleukin-27 receptor α subunit (WSX-1) prevents spontaneous skin inflammation in MRL/lpr mice. Br. J. Dermatol. 2011, 164:1214-1220.
79. Knobler R.L., Panitch H.S., Braheny S.L., Sipe J.C., Rice G.P., Huddlestone J.R., Francis G.S., Hooper C.K., Kamin-Lewis R.M., Johnson K.P. Systemic alpha-interferon therapy of multiple sclerosis. Neurology 1984, 34:1273-1279.
80. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:566-573.
81. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Annu. Rev. Immunol. 2009, 27:485-517.
82. Kurihara N., Roodman G.D. Interferons-α and -γ inhibit interleukin-1β-stimulated osteoclast-like cell formation in long-term human marrow cultures. J. Interferon Res. 1990, 10:541-547.
83. Laroni A., Gandhi R., Beynon V., Weiner H.L. IL-27 imparts immunoregulatory function to human NK cell subsets. PLoS One 2011, 6:e26173.
84. Larousserie F., Charlot P., Bardel E., Froger J., Kastelein R.A., Devergne O. Differential effects of IL-27 on human B cell subsets. J. Immunol. 2006, 176:5890-5897.
85. Larousserie F., Pflanz S., Coulomb-L'Hermine A., Brousse N., Kastelein R., Devergne O. Expression of IL-27 in human Th1-associated granulomatous diseases. J. Pathol. 2004, 202:164-171.
86. Leonard J.P., Sherman M.L., Fisher G.L., Buchanan L.J., Larsen G., Atkins M.B., Sosman J.A., Dutcher J.P., Vogelzang N.J., Ryan J.L. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood 1997, 90:2541-2548.
87. Li C.S., Zhang Q., Lee K.J., Cho S.W., Lee K.M., Hahm K.B., Choi S.C., Yun K.J., Chung H.T., Chae S.C. Interleukin-27 polymorphisms are associated with inflammatory bowel diseases in a Korean population. J. Gastroenterol. Hepatol. 2009, 24:1692-1696.
88. Li Y., Karlin A., Loike J.D., Silverstein S.C. Determination of the critical concentration of neutrophils required to block bacterial growth in tissues. J. Exp. Med. 2004, 200:613-622.
89. Liu H., Rohowsky-Kochan C. Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signaling protein 1. J. Interferon Cytokine Res. 2011, 31:459-469.
90. Liu J., Guan X., Ma X. Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-gamma-mediated pathways. J. Exp. Med. 2007, 204:141-152.
91. Liu L., Okada S., Kong X.F., Kreins A.Y., Cypowyj S., Abhyankar A., Toubiana J., Itan Y., Audry M., Nitschke P., et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 2011, 208:1635-1648.
92. Lucas S., Ghilardi N., Li J., de Sauvage F.J. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA 2003, 100:15047-15052.
93. Lupardus P.J., Skiniotis G., Rice A.J., Thomas C., Fischer S., Walz T., Garcia K.C. Structural snapshots of full-length Jak1, a transmembrane gp130/IL-6/IL-6Ralpha cytokine receptor complex, and the receptor-Jak1 holocomplex. Structure 2011, 19:45-55.
94. Lust J.A., Donovan K.A., Kline M.P., Greipp P.R., Kyle R.A., Maihle N.J. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 1992, 4:96-100.
95. Lutticken C., Wegenka U.M., Yuan J., Buschmann J., Schindler C., Ziemiecki A., Harpur A.G., Wilks A.F., Yasukawa K., Taga T. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 1994, 263:89-92.
96. Marshall E. Sciencescope. Science 1995, 268:1555.
97. Mayer K.D., Mohrs K., Reiley W., Wittmer S., Kohlmeier J.E., Pearl J.E., Cooper A.M., Johnson L.L., Woodland D.L., Mohrs M. Cutting edge: T-bet and IL-27R are critical for in vivo IFN-gamma production by CD8 T cells during infection. J. Immunol. 2008, 180:693-697.
98. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., Cua D.J. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 2007, 8:1390-1397.
99. Miyazaki Y., Inoue H., Matsumura M., Matsumoto K., Nakano T., Tsuda M., Hamano S., Yoshimura A., Yoshida H. Exacerbation of experimental allergic asthma by augmented Th2 responses in WSX-1-deficient mice. J. Immunol. 2005, 175:2401-2407.
100. Molle C., Goldman M., Goriely S. Critical role of the IFN-stimulated gene factor 3 complex in TLR-mediated IL-27p28 gene expression revealing a two-step activation process. J. Immunol. 2010, 184:1784-1792.
101. Molle C., Nguyen M., Flamand V., Renneson J., Trottein F., De Wit D., Willems F., Goldman M., Goriely S. IL-27 synthesis induced by TLR ligation critically depends on IFN regulatory factor 3. J. Immunol. 2007, 178:7607-7615.
102. Monteyne P., Van Broeck J., Van Snick J., Coutelier J. Inhibition by lactate dehydrogenase-elevating virus of in vivo interleukin 4 production during immunization with keyhole limpet haemocyanin. Cytokine 1993, 5:394-397.
103. Morishima N., Mizoguchi I., Okumura M., Chiba Y., Xu M., Shimizu M., Matsui M., Mizuguchi J., Yoshimoto T. A pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes. J. Biomed. Biotechnol. 2010, 2010:605483.
104. Morishima N., Owaki T., Asakawa M., Kamiya S., Mizuguchi J., Yoshimoto T. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27. J. Immunol. 2005, 175:1686-1693.
105. Murugaiyan G., Mittal A., Lopez-Diego R., Maier L.M., Anderson D.E., Weiner H.L. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J. Immunol. 2009, 183:2435-2443.
106. Nagai T., Devergne O., van Seventer G.A., van Seventer J.M. Interferon-beta mediates opposing effects on interferon-gamma-dependent Interleukin-12 p70 secretion by human monocyte-derived dendritic cells Scand. J. Immunol. 2007, 65:107-117.
107. Nakae S., Nambu A., Sudo K., Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 2003, 171:6173-6177.
108. Narazaki M., Witthuhn B.A., Yoshida K., Silvennoinen O., Yasukawa K., Ihle J.N., Kishimoto T., Taga T. Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130. Proc. Natl. Acad. Sci. USA 1994, 91:2285-2289.
109. Neufert C., Becker C., Wirtz S., Fantini M.C., Weigmann B., Galle P.R., Neurath M.F. IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. Eur. J. Immunol. 2007, 37:1809-1816.
110. Neyer L.E., Grunig G., Fort M., Remington J.S., Rennick D., Hunter C.A. Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect. Immun. 1997, 65:1675-1682.
111. Nicholson S.E., De Souza D., Fabri L.J., Corbin J., Willson T.A., Zhang J.G., Silva A., Asimakis M., Farley A., Nash A.D., et al. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc. Natl. Acad. Sci. USA 2000, 97:6493-6498.
112. Niedbala W., Cai B., Wei X., Patakas A., Leung B.P., McInnes I.B., Liew F.Y. Interleukin 27 attenuates collagen-induced arthritis. Ann. Rheum. Dis. 2008, 67:1474-1479.
113. Niedbala W., Wei X.Q., Cai B., Hueber A.J., Leung B.P., McInnes I.B., Liew F.Y. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur. J. Immunol. 2007, 37:3021-3029.
114. Nieuwenhuis E.E., Neurath M.F., Corazza N., Iijima H., Trgovcich J., Wirtz S., Glickman J., Bailey D., Yoshida M., Galle P.R., et al. Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc. Natl. Acad. Sci. USA 2002, 99:16951-16956.
115. Novick D., Engelmann H., Wallach D., Rubinstein M. Soluble cytokine receptors are present in normal human urine. J. Exp. Med. 1989, 170:1409-1414.
116. O'Shea J.J., Lahesmaa R., Vahedi G., Laurence A., Kanno Y. Genomic views of STAT function in CD4+ T helper cell differentiation. Nat. Rev. Immunol. 2011, 11:239-250.
117. Ouyang W., Rutz S., Crellin N.K., Valdez P.A., Hymowitz S.G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 2011, 29:71-109.
118. Owaki T., Asakawa M., Fukai F., Mizuguchi J., Yoshimoto T. IL-27 induces Th1 differentiation via p38 MAPK/T-bet- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways. J. Immunol. 2006, 177:7579-7587.
119. Owaki T., Asakawa M., Morishima N., Hata K., Fukai F., Matsui M., Mizuguchi J., Yoshimoto T. A role for IL-27 in early regulation of Th1 differentiation. J. Immunol. 2005, 175:2191-2200.
120. Ozaki K., Spolski R., Ettinger R., Kim H.P., Wang G., Qi C.F., Hwu P., Shaffer D.J., Akilesh S., Roopenian D.C., et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J. Immunol. 2004, 173:5361-5371.
121. Ozaki K., Spolski R., Feng C.G., Qi C.F., Cheng J., Sher A., Morse H.C., Liu C., Schwartzberg P.L., Leonard W.J. A critical role for IL-21 in regulating immunoglobulin production. Science 2002, 298:1630-1634.
122. Passos S.T., Silver J.S., O'Hara A.C., Sehy D., Stumhofer J.S., Hunter C.A. IL-6 promotes NK cell production of IL-17 during toxoplasmosis. J. Immunol. 2010, 184:1776-1783.
123. Pflanz S., Hibbert L., Mattson J., Rosales R., Vaisberg E., Bazan J.F., Phillips J.H., McClanahan T.K., de Waal Malefyt R., Kastelein R.A. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 2004, 172:2225-2231.
124. Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., Hibbert L., Churakova T., Travis M., Vaisberg E., et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002, 16:779-790.
125. Pickens S.R., Chamberlain N.D., Volin M.V., Mandelin A.M., Agrawal H., Matsui M., Yoshimoto T., Shahrara S. Local expression of interleukin-27 ameliorates collagen-induced arthritis. Arthritis Rheum. 2011, 63:2289-2298.
126. Pirhonen J., Siren J., Julkunen I., Matikainen S. IFN-alpha regulates Toll-like receptor-mediated IL-27 gene expression in human macrophages. J. Leukoc. Biol. 2007, 82:1185-1192.
127. Pot C., Apetoh L., Awasthi A., Kuchroo V.K. Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells. J. Interferon Cytokine Res. 2010, 30:381-388.
128. Pot C., Jin H., Awasthi A., Liu S.M., Lai C.Y., Madan R., Sharpe A.H., Karp C.L., Miaw S.C., Ho I.C., Kuchroo V.K. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 2009, 183:797-801.
129. Pradhan A., Lambert Q.T., Reuther G.W. Transformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptor. Proc. Natl. Acad. Sci. USA 2007, 104:18502-18507.
130. Rakemann T. The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitro. J. Biol. Chem. 1999, 274:1257-1266.
131. Remoli M.E., Gafa V., Giacomini E., Severa M., Lande R., Coccia E.M. IFN-beta modulates the response to TLR stimulation in human DC: Involvement of IFN regulatory factor-1 (IRF-1) in IL-27 gene expression. Eur. J. Immunol. 2007, 37:3499-3508.
132. Robinson C.M., Nau G.J. Interleukin-12 and interleukin-27 regulate macrophage control of Mycobacterium tuberculosis. J. Infect. Dis. 2008, 198:359-366.
133. Rosas L.E., Satoskar A.A., Roth K.M., Keiser T.L., Barbi J., Hunter C., de Sauvage F.J., Satoskar A.R. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology. Am. J. Pathol. 2006, 168:158-169.
134. Rousseau F., Basset L., Froger J., Dinguirard N., Chevalier S., Gascan H. IL-27 structural analysis demonstrates similarities with ciliary neurotrophic factor (CNTF) and leads to the identification of antagonistic variants [Immunology]. Proc. Natl. Acad. Sci. USA 2010, 107:19420-19425.
135. Saito M., Yoshida K., Hibi M., Taga T., Kishimoto T. Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. J. Immunol. 1992, 148:4066-4071.
136. Salcedo R., Hixon J.A., Stauffer J.K., Jalah R., Brooks A.D., Khan T., Dai R.M., Scheetz L., Lincoln E., Back T.C., et al. Immunologic and therapeutic synergy of IL-27 and IL-2: Enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow. J. Immunol. 2009, 182:4328-4338.
137. Salcedo R., Stauffer J.K., Lincoln E., Back T.C., Hixon J.A., Hahn C., Shafer-Weaver K., Malyguine A., Kastelein R., Wigginton J.M. IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: Role for CD8+ T cells. J. Immunol. 2004, 173:7170-7182.
138. Sasaoka T., Ito M., Yamashita J., Nakajima K., Tanaka I., Narita M., Hara Y., Hada K., Takahashi M., Ohno Y., et al. Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 300:G568-G576.
139. Scheller J., Schuster B., Holscher C., Yoshimoto T., Rose-John S. No inhibition of IL-27 signaling by soluble gp130. Biochem. Biophys. Res. Commun. 2005, 326:724-728.
140. Schneider R., Yaneva T., Beauseigle D., El-Khoury L., Arbour N. IL-27 increases the proliferation and effector functions of human naive CD8+ T lymphocytes and promotes their development into Tc1 cells. Eur. J. Immunol. 2011, 41:47-59.
141. Schuetze N., Schoeneberger S., Mueller U., Freudenberg M.A., Alber G., Straubinger R.K. IL-12 family members: Differential kinetics of their TLR4-mediated induction by Salmonella enteritidis and the impact of IL-10 in bone marrow-derived macrophages. Int. Immunol. 2005, 17:649-659.
142. Seita J., Asakawa M., Ooehara J., Takayanagi S., Morita Y., Watanabe N., Fujita K., Kudo M., Mizuguchi J., Ema H., Nakauchi H., Yoshimoto T. Interleukin-27 directly induces differentiation in hematopoietic stem cells. Blood 2008, 111:1903-1912.
143. Shimanoe Y., Miyazaki Y., Hara H., Inokuchi A., Yoshida H. Amelioration of experimental allergic rhinitis with suppression of topical immune responses by lack of IL-27/WSX-1 signaling. Ann. Allergy Asthma Immunol. 2009, 102:223-232.
144. Shimizu S., Sugiyama N., Masutani K., Sadanaga A., Miyazaki Y., Inoue Y., Akahoshi M., Katafuchi R., Hirakata H., Harada M., et al. Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1). J. Immunol. 2005, 175:7185-7192.
145. Shin M.S., Lee N., Kang I. Effector T-cell subsets in systemic lupus erythematosus: Update focusing on Th17 cells. Curr. Opin. Rheumatol. 2011, 23:444-448.
146. Shinohara M.L., Kim J.H., Garcia V.A., Cantor H. Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: Role of intracellular osteopontin. Immunity 2008, 29:68-78.
147. Shinozaki Y., Wang S., Miyazaki Y., Miyazaki K., Yamada H., Yoshikai Y., Hara H., Yoshida H. Tumor-specific cytotoxic T cell generation and dendritic cell function are differentially regulated by interleukin 27 during development of anti-tumor immunity. Int. J. Cancer 2009, 124:1372-1378.
148. Smits H.H., van Beelen A.J., Hessle C., Westland R., de Jong E., Soeteman E., Wold A., Wierenga E.A., Kapsenberg M.L. Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development. Eur. J. Immunol. 2004, 34:1371-1380.
149. Sonobe Y., Yawata I., Kawanokuchi J., Takeuchi H., Mizuno T., Suzumura A. Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations. Brain Res. 2005, 1040:202-207.
150. Sprecher C.A., Grant F.J., Baumgartner J.W., Presnell S.R., Schrader S.K., Yamagiwa T., Whitmore T.E., O'Hara P.J., Foster D.F. Cloning and characterization of a novel class I cytokine receptor. Biochem. Biophys. Res. Commun. 1998, 246:82-90.
151. Stahl N., Boulton T.G., Farruggella T., Ip N.Y., Davis S., Witthuhn B.A., Quelle F.W., Silvennoinen O., Barbieri G., Pellegrini S. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 1994, 263:92-95.
152. Stephan M.T., Moon J.J., Um S.H., Bershteyn A., Irvine D.J. Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. Nat. Med. 2010, 16:1035-1041.
153. Stumhofer J.S., Laurence A., Wilson E.H., Huang E., Tato C.M., Johnson L.M., Villarino A.V., Huang Q., Yoshimura A., Sehy D., et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 2006, 7:937-945.
154. Stumhofer J.S., Silver J.S., Laurence A., Porrett P.M., Harris T.H., Turka L.A., Ernst M., Saris C.J., O'Shea J.J., Hunter C.A. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 2007, 8:1363-1371.
155. Stumhofer J.S., Tait E.D., Quinn W.J., Hosken N., Spudy B., Goenka R., Fielding C.A., O'Hara A.C., Chen Y., Jones M.L., et al. A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat. Immunol. 2010, 11:1119-1126.
156. Sugiyama N., Nakashima H., Yoshimura T., Sadanaga A., Shimizu S., Masutani K., Igawa T., Akahoshi M., Miyake K., Takeda A., et al. Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1). Ann. Rheum. Dis. 2008, 67:1461-1467.
157. Sun J., Dodd H., Moser E.K., Sharma R., Braciale T.J. CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs. Nat. Immunol. 2011, 12:327-334.
158. Sweeney C.M., Lonergan R., Basdeo S.A., Kinsella K., Dungan L.S., Higgins S.C., Kelly P.J., Costelloe L., Tubridy N., Mills K.H., Fletcher J.M. IL-27 mediates the response to IFN-beta therapy in multiple sclerosis patients by inhibiting Th17 cells. Brain Behav. Immun. 2011, 25:1170-1181.
159. Taga T., Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 1997, 15:797-819.
160. Tait Wojno E.D., Hosken N., Stumhofer J.S., O'Hara A.C., Mauldin E., Fang Q., Turka L.A., Levin S.D., Hunter C.A. A role for IL-27 in limiting T regulatory cell populations. J. Immunol. 2011, 187:266-273.
161. Takeda A., Hamano S., Yamanaka A., Hanada T., Ishibashi T., Mak T.W., Yoshimura A., Yoshida H. Cutting edge: Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 2003, 170:4886-4890.
162. Traum D., Timothee P., Silver J., Rose-John S., Ernst M., Larosa D.F. IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling. J. Leukoc. Biol. 2011, 91:427-435.
163. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003, 3:133-146.
164. Troy A.E., Zaph C., Du Y., Taylor B.C., Guild K.J., Hunter C.A., Saris C.J., Artis D. IL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis. J. Immunol. 2009, 183:2037-2044.
165. van de Veerdonk F.L., Plantinga T.S., Hoischen A., Smeekens S.P., Joosten L.A., Gilissen C., Arts P., Rosentul D.C., Carmichael A.J., Graaf C.A., et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N. Engl. J. Med. 2011, 365:54-61.
166. van Seventer J.M., Nagai T., van Seventer G.A. Interferon-beta differentially regulates expression of the IL-12 family members p35, p40, p19 and EBI3 in activated human dendritic cells. J. Neuroimmunol. 2002, 133:60-71.
167. Veckman V., Miettinen M., Pirhonen J., Siren J., Matikainen S., Julkunen I. Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells. J. Leukoc. Biol. 2004, 75:764-771.
168. Villarino A., Hibbert L., Lieberman L., Wilson E., Mak T., Yoshida H., Kastelein R.A., Saris C., Hunter C.A. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 2003, 19:645-655.
169. Villarino A.V., Gallo E., Abbas A.K. STAT1-activating cytokines limit Th17 responses through both T-bet-dependent and -independent mechanisms. J. Immunol. 2010, 185:6461-6471.
170. Villarino A.V., Larkin J., Saris C.J., Caton A.J., Lucas S., Wong T., de Sauvage F.J., Hunter C.A. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J. Immunol. 2005, 174:7684-7691.
171. Villarino A.V., Stumhofer J.S., Saris C.J., Kastelein R.A., de Sauvage F.J., Hunter C.A. IL-27 limits IL-2 production during Th1 differentiation. J. Immunol. 2006, 176:237-247.
172. Villarino A.V., Tato C.M., Stumhofer J.S., Yao Z., Cui Y.K., Hennighausen L., O'Shea J.J., Hunter C.A. Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals. J. Exp. Med. 2007, 204:65-71.
173. Wang J., Wang G., Sun B., Li H., Mu L., Wang Q., Li G., Shi L., Jin L., Kostulas N. Interleukin-27 suppresses experimental autoimmune encephalomyelitis during bone marrow stromal cell treatment. J. Autoimmun. 2008, 30:222-229.
174. Wang S., Miyazaki Y., Shinozaki Y., Yoshida H. Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1(IL-27R) deficiency. J. Immunol. 2007, 179:6421-6428.
175. Wang X.J., Taga T., Yoshida K., Saito M., Kishimoto T., Kikutani H. gp130, the cytokine common signal-transducer of interleukin-6 cytokine family, is downregulated in T cells in vivo by interleukin-6. Blood 1998, 91:3308-3314.
176. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992, 356:314-317.
177. Wilson E.H., Wille-Reece U., Dzierszinski F., Hunter C.A. A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J. Neuroimmunol. 2005, 165:63-74.
178. Wirtz S., Becker C., Fantini M.C., Nieuwenhuis E.E., Tubbe I., Galle P.R., Schild H.J., Birkenbach M., Blumberg R.S., Neurath M.F. EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation. J. Immunol. 2005, 174:2814-2824.
179. Wirtz S., Tubbe I., Galle P.R., Schild H.J., Birkenbach M., Blumberg R.S., Neurath M.F. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J. Exp. Med. 2006, 203:1875-1881.
180. Wittmann M., Zeitvogel J., Wang D., Werfel T. IL-27 is expressed in chronic human eczematous skin lesions and stimulates human keratinocytes. J. Allergy Clin. Immunol. 2009, 124:81-89.
181. Wojno E.D., Hosken N., Stumhofer J.S., O'Hara A.C., Mauldin E., Fang Q., Turka L.A., Levin S.D., Hunter C.A. A role for IL-27 in limiting T regulatory cell populations. J. Immunol. 2011, 187:266-273.
182. Xu J., Yang Y., Qiu G., Lal G., Wu Z., Levy D.E., Ochando J.C., Bromberg J.S., Ding Y. c-Maf regulates IL-10 expression during Th17 polarization. J. Immunol. 2009, 182:6226-6236.
183. Yamasaki K., Taga T., Hirata Y., Yawata H., Kawanishi Y., Seed B., Taniguchi T., Hirano T., Kishimoto T. Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science 1988, 241:825-828.
184. Yang J., Yang M., Htut T.M., Ouyang X., Hanidu A., Li X., Sellati R., Jiang H., Zhang S., Li H., et al. Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t. Eur. J. Immunol. 2008, 38:1204-1214.
185. Yoshida H., Hamano S., Senaldi G., Covey T., Faggioni R., Mu S., Xia M., Wakeham A.C., Nishina H., Potter J., Saris C.J., Mak T.W. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 2001, 15:569-578.
186. Yoshimoto T., Morishima N., Mizoguchi I., Shimizu M., Nagai H., Oniki S., Oka M., Nishigori C., Mizuguchi J. Antiproliferative activity of IL-27 on melanoma. J. Immunol. 2008, 180:6527-6535.
187. Yoshimoto T., Okada K., Morishima N., Kamiya S., Owaki T., Asakawa M., Iwakura Y., Fukai F., Mizuguchi J. Induction of IgG2a class switching in B cells by IL-27. J. Immunol. 2004, 173:2479-2485.
188. Yoshimoto T., Yoshimoto T., Yasuda K., Mizuguchi J., Nakanishi K. IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: A novel therapeutic way for Th2-mediated allergic inflammation. J. Immunol. 2007, 179:4415-4423.
189. Yoshimura T., Takeda A., Hamano S., Miyazaki Y., Kinjyo I., Ishibashi T., Yoshimura A., Yoshida H. Two-sided roles of IL-27: Induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J. Immunol. 2006, 177:5377-5385.
190. Yoshizaki A., Yanaba K., Iwata Y., Komura K., Ogawa A., Muroi E., Ogawa F., Takenaka M., Shimizu K., Hasegawa M., Fujimoto M., Sato S. Elevated serum interleukin-27 levels in patients with systemic sclerosis: Association with T cell, B cell and fibroblast activation. Ann. Rheum. Dis. 2011, 70:194-200.
191. Zahn S., Wirtz S., Birkenbach M., Blumberg R.S., Neurath M.F., von Stebut E. Impaired Th1 responses in mice deficient in Epstein-Barr virus-induced gene 3 and challenged with physiological doses of Leishmania major. Eur. J. Immunol. 2005, 35:1106-1112.
192. Zhang J., Qian X., Ning H., Eickhoff C.S., Hoft D.F., Liu J. Transcriptional suppression of IL-27 production by Mycobacterium tuberculosis-activated p38 MAPK via inhibition of AP-1 binding. J. Immunol. 2011, 186:5885-5895.
193. Zhang J., Qian X., Ning H., Yang J., Xiong H., Liu J. Activation of IL-27 p28 gene transcription by interferon regulatory factor 8 in cooperation with interferon regulatory factor 1. J. Biol. Chem. 2010, 285:21269-21281.
194. Zhang J.H., He H., Borzychowski A.M., Takeda K., Akira S., Croy B.A. Analysis of cytokine regulators inducing interferon production by mouse uterine natural killer cells. Biol. Reprod. 2003, 69:404-411.